• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Screening for osteoporosis in men receiving androgen deprivation therapy.

作者信息

Alibhai Shabbir M H, Yun Lingsong, Cheung Angela M, Paszat Lawrence

机构信息

Department of Medicine, University Health Network, Toronto, Ontario, Canada.

出版信息

JAMA. 2012 Jan 18;307(3):255-6. doi: 10.1001/jama.2011.2022.

DOI:10.1001/jama.2011.2022
PMID:22253389
Abstract
摘要

相似文献

1
Screening for osteoporosis in men receiving androgen deprivation therapy.接受雄激素剥夺治疗的男性骨质疏松症筛查。
JAMA. 2012 Jan 18;307(3):255-6. doi: 10.1001/jama.2011.2022.
2
Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy.在雄激素剥夺治疗期间进行骨密度检测及开具预防或治疗骨质疏松症药物的医生诊疗行为。
Cancer. 2005 Jan 15;103(2):237-41. doi: 10.1002/cncr.20766.
3
Bone health management in prostate cancer patients receiving androgen deprivation therapy.接受雄激素剥夺治疗的前列腺癌患者的骨骼健康管理。
J Oncol Pharm Pract. 2012 Mar;18(1):84-90. doi: 10.1177/1078155211402105. Epub 2011 Aug 1.
4
Practical guide to the management of osteoporosis in men with prostate cancer receiving androgen-deprivation therapy.接受雄激素剥夺治疗的前列腺癌男性骨质疏松症管理实用指南。
Curr Urol Rep. 2005 May;6(3):157-8. doi: 10.1007/s11934-005-0001-x.
5
Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies.接受雄激素剥夺治疗的前列腺癌男性患者的骨质疏松症：诊断和治疗建议
Cancer. 2004 Mar 1;100(5):892-9. doi: 10.1002/cncr.20056.
6
Osteoporosis knowledge, health beliefs, and healthy bone behaviours in patients on androgen-deprivation therapy (ADT) for prostate cancer.骨质疏松症知识、健康信念和前列腺癌雄激素剥夺治疗（ADT）患者的健康骨骼行为。
BJU Int. 2013 Jun;111(8):1301-9. doi: 10.1111/j.1464-410X.2012.11777.x. Epub 2013 Jan 25.
7
Osteoporosis from androgen deprivation therapy in prostate cancer treatment.前列腺癌治疗中雄激素剥夺疗法所致的骨质疏松症。
Aust Fam Physician. 2006 Apr;35(4):243-5.
8
A comparison of dual energy X-ray absorptiometry of the hip and accuDEXA of the finger for the diagnosis of osteoporosis in men on androgen deprivation therapy for advanced prostate cancer.对于接受雄激素剥夺治疗的晚期前列腺癌男性患者，比较髋部双能X线吸收法与手指骨密度仪（accuDEXA）在骨质疏松症诊断中的应用。
Prostate Cancer Prostatic Dis. 2007;10(1):94-6. doi: 10.1038/sj.pcan.4500913. Epub 2006 Sep 26.
9
The role of bisphosphonates in men with prostate cancer receiving androgen deprivation therapy.双膦酸盐在接受雄激素剥夺治疗的前列腺癌男性患者中的作用。
Oncology (Williston Park). 2004 May;18(5 Suppl 3):21-5.
10
Low rate of bone density testing in men receiving androgen deprivation therapy.接受雄激素剥夺治疗的男性进行骨密度检测的比例较低。
CA Cancer J Clin. 2013 Mar-Apr;63(2):85-6. doi: 10.3322/caac.21176. Epub 2013 Jan 14.

引用本文的文献

1
Remote Bone Health Service for Osteoporosis Screening in High-Risk Men: A Cluster Randomized Clinical Trial.针对高危男性骨质疏松症筛查的远程骨骼健康服务：一项整群随机临床试验
JAMA Intern Med. 2025 Aug 25. doi: 10.1001/jamainternmed.2025.4150.
2
Bone Health Management in Men Commencing Androgen Deprivation Therapy for Prostate Cancer and Women Commencing Anti-Oestrogen Therapy for Breast Cancer.开始接受前列腺癌雄激素剥夺治疗的男性及开始接受乳腺癌抗雌激素治疗的女性的骨骼健康管理。
Cancer Med. 2025 May;14(9):e70873. doi: 10.1002/cam4.70873.
3
Relationship between Femoral Proximal Bone Quality Assessment by MRI IDEAL-IQ Sequence and Body Mass Index in Elderly Men.
老年人股骨近端骨质量评估与 MRI IDEAL-IQ 序列和体重指数的关系。
Tomography. 2024 May 20;10(5):816-825. doi: 10.3390/tomography10050062.
4
Bone health assessment with dual energy X-ray absorptiometry in men with high-risk prostate carcinoma commencing adjuvant androgen deprivation therapy.对开始辅助雄激素剥夺治疗的高危前列腺癌男性患者进行双能X线吸收法骨健康评估。
Rep Pract Oncol Radiother. 2022 Sep 19;27(4):677-683. doi: 10.5603/RPOR.a2022.0069. eCollection 2022.
5
Implementing and Evaluating the Impact of BoneRx: A Healthy Bone Prescription for Men with Prostate Cancer Initiating Androgen Deprivation Therapy.实施与评估BoneRx的影响：为开始雄激素剥夺治疗的前列腺癌男性提供的健康骨骼处方
J Clin Med. 2022 May 11;11(10):2703. doi: 10.3390/jcm11102703.
6
Assessment of bone health in patients with prostate cancer using cancer staging computed tomography.使用癌症分期 CT 评估前列腺癌患者的骨骼健康状况。
J Bone Miner Metab. 2022 Jul;40(4):648-656. doi: 10.1007/s00774-022-01328-4. Epub 2022 May 12.
7
Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer.接受雄激素剥夺疗法治疗局限性或区域性前列腺癌的老年男性中，骨密度检测与主要骨质疏松性骨折风险的相关性。
JAMA Netw Open. 2022 Apr 1;5(4):e225432. doi: 10.1001/jamanetworkopen.2022.5432.
8
Effects of once-yearly zoledronic acid on bone density and incident vertebral fractures in nonmetastatic castration-sensitive prostate cancer patients with osteoporosis.唑来膦酸治疗骨质疏松的非转移性去势敏感性前列腺癌患者骨密度和新发椎体骨折的影响。
BMC Cancer. 2021 Apr 17;21(1):422. doi: 10.1186/s12885-021-08177-w.
9
Osteoporosis screening using computed tomography for men with prostate cancer: results of a prospective study.使用计算机断层扫描对前列腺癌男性进行骨质疏松症筛查：一项前瞻性研究的结果。
Arch Osteoporos. 2020 Feb 29;15(1):32. doi: 10.1007/s11657-020-0711-1.
10
The skeletal impact of cancer therapies.癌症治疗对骨骼的影响。
Br J Clin Pharmacol. 2019 Jun;85(6):1161-1168. doi: 10.1111/bcp.13866. Epub 2019 Feb 21.